跳至主要内容
临床试验/CTRI/2025/09/095301
CTRI/2025/09/095301尚未招募4 期

Efficacy of retrolaminar and paravertebral block for postoperative analgesia in percutaneous nephrolithotomy patients - A double-blinded randomized controlled trial

Dharshini K1 个研究点 分布在 1 个国家目标入组 104 人开始时间: 2025年10月15日最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
104
试验地点
1
主要终点
Duration of postoperative anlagesia provided by retrolaminar block verus paravertebral block in patients undergoing percutaneous nephrolithotomy

研究概览

简要总结

This double blinded randomized controlled trial aims to compare the postoperative analgesic efficacy of ultrasound guided retrolaminar block and paravertebral block in patients undergoing percutaneous nephrolithotomy under spinal anesthesia. After detailed preanesthetic evaluation, patients will be randomized into two groups: Group A - receiving RLB at the T10 level and Group B- receieving PVB at the T10 level , each with 20ml of 0.25% bupivacaine following saline confirmation of needle placement . All patients will receive standard anesthesia. Postoperatively, pain will be asssessed using the Visual Analog scala (VAS) at regular intervals over 24 hours by an independent blinded observer. The primary outcome is the duration of postoperative analgesia, defined as the time to first rescue anlagesia, while secondary  outcomes include pain scores, total rescue analgesia consumption, and block related complications.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant and Investigator Blinded

入排标准

年龄范围
20.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • ASA PS I, II and III
  • Patient posted for elective PCNL.

排除标准

  • patient not giving consent obesity allergy to drugs.

结局指标

主要结局

Duration of postoperative anlagesia provided by retrolaminar block verus paravertebral block in patients undergoing percutaneous nephrolithotomy

时间窗: first 24 hours

次要结局

  • Pain scores(postoperative period first 24 hours)
  • Total rescue analgesic consumption(postoperative period first 24 hours)
  • Block related complications(postoperative period first 24 hours)

研究者

发起方
Dharshini K
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dharshini K

Sri Manakula Vinayagar medical College and Hospital

研究点 (1)

Loading locations...

相似试验